Remove 2003 Remove Compliance Remove World Health
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – May And June

SQA

Additional concerns were noted with respect to: Temperature/humidity controls Calibration inspection and/or qualification of equipment, including computerized systems Equipment usage logs Release of finished products Change Control Records Quality Agreement(s) Specifications for finished products Retention samples Bausch Health, Canada Inc.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – May And June

SQA

Additional concerns were noted with respect to: Temperature/humidity controls Calibration inspection and/or qualification of equipment, including computerized systems Equipment usage logs Release of finished products Change Control Records Quality Agreement(s) Specifications for finished products Retention samples Bausch Health, Canada Inc.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary for March and April 2024

SQA

Companies participating in the program will receive annual audits to monitor the risk and verify the maintenance of compliance with GMP, contributing to the control of the health risk of the products. Non-Compliance Rating for Upmaid Technologies Inc., This indicated a lack of proper implementation of the necessary CAPAs.

FDA 40